| Tag | Content |
|---|
EnhancerAtlas ID | HS091-25345 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr2:24526730-24528750 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| MAX | MA0058.3 | chr2:24526861-24526871 | ACCACGTGCT | + | 6.02 | | POU4F2 | MA0683.1 | chr2:24526781-24526797 | ATGCATAACAAATTAG | + | 6.29 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_58730 | chr2:24526530-24584673 | Ly1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I024303 | chr2 | 24526500 | 24528278 |
|
Enhancer Sequence | CCTGATTAAG TGGGGAAAAT CATAAAGGAA TTCTTTAGCA TCTTTAAAGT TATGCATAAC 60
AAATTAGCTG TATCTGTAAA ATAACAATGC TACCAGGGTA TCCTGGGAAC TTTTAACATC 120
AAAATGTTTT TACCACGTGC TAGGTGCTAA GCATTCAGTA GCAATTAAAC CCAGTCACTG 180
CCCCAAGGAA TTTTAAATCT AGAATTAGCA GTATCAAGTG CTGTCCCCTG TCTTTTCAGC 240
AAGATAATAA TACACACAAG TGGCTAACGT GAAAGAACAA GATATCAGGC ACACAGAGTA 300
TCAGAGGCCA AGACTGTGGG CCCTCTTGTA CTCCCAGCAG GTGCAGCACT TCCCACTCCT 360
ACGTGACTGA GCCGTGAGTA GCAGAAGAGT CAGGCGCTAC TCTGGGTTCA GCCTGAGTCA 420
AGGCCTGTCC AAAACAACTC TTACACAAGA GATTACATCT GCCAACACTG CCTCAGCAAC 480
AGCTCCAACT ACAACAAAAG CCAGCCAAAT GCAGCTAGAT TTATTGTCCC ACTAGGCTTT 540
CAACATAGGA CTTGATAATC AAAGCAACCA TGTATTACAA CATGCAGCTA AATGTTTATA 600
TTTTATAACT TTTAAAATAT TTTCATTCTA TTTTTTTAAT CTGGACATTT AACATAAATC 660
ACATAAAAAC ACTGGAAATT AAACTCACAG CCTCGCCCTA TTAATTACTC CTCAGATTTC 720
ACTTAGGAAA TTTGATTTGA GGAGGTCTTT GTGTTAAAAG GAAGATTCTT CTAAATAAGA 780
GAGATGGAAG GCTATTTCAA ACCTGAAAAA AAGTTCAAAA CTACTATTTC AGCTTTTGGA 840
CCGAAAAAAG ATCCTTTTGG ACTGAAAGAA GATCCCTTAG CATCAGGCAA TAGAGCAAAC 900
AGAAGAGAGA AGGAGGAGGA ATGTAAATGG TTAAAAATCA TACTCGTGGA GGGCTTTATA 960
TGTGTGAGGC AAAGTCTGAG TAATACAAAG GGCCATAGAG AGCCAACAGA GTATCTTACT 1020
TACTAAGTAA AACTCATTTG AACATGTATG TACACTCTTA GTCGGCCAAG CCTCTGGATA 1080
TCCTATATCC TCTGCTTAGA ATGCCAGACC CTCAATTCTT TACTTTGTAG TCTATCCTCT 1140
GAAATCTGGC TCTAATCTCT TTTCTTCTGT GAAACATTCT CTCTTATATC CTTGGAGTTA 1200
GTCACTTTCT CATCTATATT AATCACAGCA CTTTTAAACA AGTAACCAAA CACCTTGATT 1260
ACATGAGCTC TTCATTATAT GGGCTCTTCA AAGATATGAA CCATGTCTTG CCCCTGTCTG 1320
TATTCCTGTG CCTAAGAGAG TGCCCAGAAA GTATGTGATT CAGGAAACAG TTACATCAAT 1380
GACTTGATCT AAATAAATTT TTAAAAACTA TGTTTAGGGG GAGGAGAAGA GAAGTAAAAA 1440
AGGGAAAAAC AGACCAGTGG ACAGGCGCGG TAGCTCACGT CTGTAATCCC AGAACTTTGG 1500
GAGACCAAGG CGGGCGGATC ACCTGAGGTT GGGAGTTCGA GACCAGCCTG GCCAACATGG 1560
CAAAACCTGT CTCTACTAAG AAAAATTAGC TGGGCGTGGT GGCGTGTGCC TGTAGGAGGC 1620
AGGAGAATCG CTGGAACCCG GGGAGGCAGA GGCTGCAGTG GGCCAAGATC GCACCACTGC 1680
ACTCCAGCCT GGGCAACAGA GCAAGACTCT GTCTCAAAAA AAAAAAAAAA AAAAAAAAAA 1740
GGATCACCAA CTCCTACACT TATTGAACAA AACAAACATA TAAGTCCAGG TTAGCCTCAT 1800
CCTCATGTTC TTGGGGCTCA TGCTCAGCTT AAGGACACCA GCAGCAACTA CTCTTTTTAT 1860
AGAAAACCTT GTCTTTACCT ACAGATATAT AGCTTTACCC TTGTAGGTCT CAGAATAATA 1920
ATGACATTCC CTAAAAAACA CCATAATACA CAACCTTCGT ACAATGTGAC ATATACTAAT 1980
GAAGTAACAT TAGGGATCAC TTCCCCACAG TTGGCTCCCC 2020
|
